APA

Lee J. J., Vilain R. E., Granter S. R., Hu N. R., Bresler S. C., Xu S., Frank A. H., Mihm M. C., Saw R. P. M., Fletcher C. D., Scolyer R. A., Murphy G. F. & Lian C. G. (20170815). 5-Hydroxymethylcytosine is a nuclear biomarker to assess biological potential in histologically ambiguous heavily pigmented melanocytic neoplasms. : Journal of cutaneous pathology.

Chicago

Lee Jonathan J, Vilain Ricardo E, Granter Scott R, Hu Nina R, Bresler Scott C, Xu Shuyun, Frank Alexander H, Mihm Martin C, Saw Robyn P M, Fletcher Christopher D, Scolyer Richard A, Murphy George F and Lian Christine G. 20170815. 5-Hydroxymethylcytosine is a nuclear biomarker to assess biological potential in histologically ambiguous heavily pigmented melanocytic neoplasms. : Journal of cutaneous pathology.

Harvard

Lee J. J., Vilain R. E., Granter S. R., Hu N. R., Bresler S. C., Xu S., Frank A. H., Mihm M. C., Saw R. P. M., Fletcher C. D., Scolyer R. A., Murphy G. F. and Lian C. G. (20170815). 5-Hydroxymethylcytosine is a nuclear biomarker to assess biological potential in histologically ambiguous heavily pigmented melanocytic neoplasms. : Journal of cutaneous pathology.

MLA

Lee Jonathan J, Vilain Ricardo E, Granter Scott R, Hu Nina R, Bresler Scott C, Xu Shuyun, Frank Alexander H, Mihm Martin C, Saw Robyn P M, Fletcher Christopher D, Scolyer Richard A, Murphy George F and Lian Christine G. 5-Hydroxymethylcytosine is a nuclear biomarker to assess biological potential in histologically ambiguous heavily pigmented melanocytic neoplasms. : Journal of cutaneous pathology. 20170815.